Generating Symmetry in the Asymmetric ATP-binding Cassette (ABC) Transporter Pdr5 from Saccharomyces cerevisiae*

  1. Lutz Schmitt1
  1. From the Institute of Biochemistry, Heinrich Heine University Düsseldorf, Universitätsstrasse 1, 40225 Düsseldorf, Germany
  1. 1 To whom correspondence should be addressed. Tel.: 49-211-81-10773; Fax: 49-211-81-15310; E-mail: lutz.schmitt{at}hhu.de.

Background: Fungal multidrug efflux pumps possess a degenerate nucleotide-binding site (NBS).

Results: Restoring all the nonconserved amino acids in the degenerate NBS of Pdr5 leads to complete loss of function of the protein.

Conclusion: The degenerate NBS is essential and acts as a structural platform supporting the canonical NBS.

Significance: This is the first study dealing with the entire degenerate NBS and its functional role.

Abstract

Pdr5 is a plasma membrane-bound ABC transporter from Saccharomyces cerevisiae and is involved in the phenomenon of resistance against xenobiotics, which are clinically relevant in bacteria, fungi, and humans. Many fungal ABC transporters such as Pdr5 display an inherent asymmetry in their nucleotide-binding sites (NBS) unlike most of their human counterparts. This degeneracy of the NBSs is very intriguing and needs explanation in terms of structural and functional relevance. In this study, we mutated nonconsensus amino acid residues in the NBSs to its consensus counterpart and studied its effect on the function of the protein and effect on yeast cells. The completely “regenerated” Pdr5 protein was severely impaired in its function of ATP hydrolysis and of rhodamine 6G transport. Moreover, we observe alternative compensatory mechanisms to counteract drug toxicity in some of the mutants. In essence, we describe here the first attempts to restore complete symmetry in an asymmetric ABC transporter and to study its effects, which might be relevant to the entire class of asymmetric ABC transporters.

Footnotes

  • * This work was supported by Deutsche Forschungsgemeinschaft Grant Schm1279/5-3 and European Drug Initiative on Channels and Transporters FP7 Theme Health-2007–2.1.1.-5 (to L. S.).

  • Received January 27, 2014.
  • Revision received March 24, 2014.
Table of Contents

This Article

  1. The Journal of Biological Chemistry 289, 15272-15279.
  1. All Versions of this Article:
    1. M114.553065v1
    2. 289/22/15272 (most recent)

Classifications

Article Usage Stats

Submit your work to JBC.

You'll be in good company.